FreakOut Holdings, inc.
FreakOut Holdings, inc. (6094.T) Financial Performance & Income Statement Overview
Explore the financials of FreakOut Holdings, inc. (6094.T), including yearly and quarterly data on income, cash flow, and balance sheets.
FreakOut Holdings, inc. (6094.T) Income Statement & Financial Overview
Access detailed annual and quarterly income data for FreakOut Holdings, inc. 6094.T financial performance.
Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
---|---|---|---|---|
Revenue | $11.61B | $13.74B | $14.18B | $12.59B |
Cost of Revenue | $8.35B | $10.04B | $10.23B | $9.14B |
Gross Profit | $3.26B | $3.68B | $3.92B | $3.45B |
Gross Profit Ratio | $0.28 | $0.27 | $0.28 | $0.27 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $3.30B | $3.55B | $3.54B | $3.67B |
Operating Expenses | $3.30B | $3.55B | $3.89B | $3.67B |
Total Costs & Expenses | $11.65B | $13.59B | $14.12B | $12.81B |
Interest Income | $14.03M | $20.42M | $22.12M | $9.45M |
Interest Expense | $41.23M | $37.42M | $49.77M | $0.00 |
Depreciation & Amortization | $285.85M | $1.09B | $1.09B | $143.75M |
EBITDA | $108.56M | $1.25B | $1.24B | -$79.25M |
EBITDA Ratio | $0.009 | $0.09 | $0.09 | -$0.006 |
Operating Income | -$38.81M | $159.00M | $57.00M | -$222.00M |
Operating Income Ratio | -$0.003 | $0.01 | $0.004 | -$0.02 |
Other Income/Expenses (Net) | -$179.70M | $438.00M | -$411.00M | $1.05B |
Income Before Tax | -$218.51M | $597.00M | -$354.00M | $830.00M |
Income Before Tax Ratio | -$0.02 | $0.04 | -$0.02 | $0.07 |
Income Tax Expense | $71.56M | $134.00M | $114.00M | $273.00M |
Net Income | -$229.98M | $436.00M | -$439.00M | $275.00M |
Net Income Ratio | -$0.02 | $0.03 | -$0.03 | $0.02 |
EPS | -$13.23 | $25.09 | -$24.91 | $15.61 |
Diluted EPS | -$13.23 | $25.09 | -$24.91 | $15.61 |
Weighted Avg Shares Outstanding | $17.38M | $17.38M | $17.62M | $17.62M |
Weighted Avg Shares Outstanding (Diluted) | $17.38M | $17.41M | $17.62M | $17.62M |
Over the past four quarters, FreakOut Holdings, inc. demonstrated steady revenue growth, increasing from $12.59B in Q3 2024 to $11.61B in Q2 2025. Operating income reached -$38.81M in Q2 2025, maintaining a consistent -0% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $108.56M, reflecting operational efficiency. Net income dropped to -$229.98M, with EPS at -$13.23. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan